Singapore markets close in 1 hour 57 minutes
Straits Times Index
3,290.20 -2.49 (-0.08%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,191.69 +428.66 (+2.41%) FTSE 100
8,121.24 0.00 (0.00%) Bitcoin USD
57,635.13 -1,708.23 (-2.88%) CMC Crypto 200
1,261.87 -8.87 (-0.70%)
Coya Therapeutics, Inc. (COYA)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 126.60M |
| Enterprise value | 142.43M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 14.68 |
| Price/book (mrq) | 3.55 |
| Enterprise value/revenue | 23.73 |
| Enterprise value/EBITDA | -19.42 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 73.75% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 10.69 |
| 52-week low 3 | 3.21 |
| 50-day moving average 3 | 9.20 |
| 200-day moving average 3 | 6.20 |
Share statistics
| Avg vol (3-month) 3 | 101.14k |
| Avg vol (10-day) 3 | 48.36k |
| Shares outstanding 5 | 14.6M |
| Implied shares outstanding 6 | 14.99M |
| Float 8 | 9.97M |
| % held by insiders 1 | 7.95% |
| % held by institutions 1 | 18.32% |
| Shares short (15 Apr 2024) 4 | 184.59k |
| Short ratio (15 Apr 2024) 4 | 1.54 |
| Short % of float (15 Apr 2024) 4 | 1.37% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.26% |
| Shares short (prior month 15 Mar 2024) 4 | 46.71k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -133.08% |
| Operating margin (ttm) | 33.46% |
Management effectiveness
| Return on assets (ttm) | -18.53% |
| Return on equity (ttm) | -58.64% |
Income statement
| Revenue (ttm) | 6M |
| Revenue per share (ttm) | 0.59 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -7.33M |
| Net income avi to common (ttm) | -7.99M |
| Diluted EPS (ttm) | -0.79 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 32.63M |
| Total cash per share (mrq) | 2.24 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 8.15 |
| Book value per share (mrq) | 2.47 |
Cash flow statement
| Operating cash flow (ttm) | -11.19M |
| Levered free cash flow (ttm) | -10.33M |
© 2024 Yahoo. All rights reserved.